SLE Disease Activity Is a More Important Risk Factor Than Immunosuppression for Acquiring Human Papillomavirus (HPV) Infection in Systemic Lupus Erythematosus Patients (ACR Convergence 2023) - Sep 24, 2023 - Abstract #1685; Pres time: Nov 13, 2023; 05:00 PM - 05:10 PM; Location: Room 25A-C; in person; "Immunosuppressive drugs were divided into 3 groups: Conventional: Methotrexate; nonbiologic: Azathioprine, Mycophenolate mofetil, Tacrolimus, Voclosporin, Cyclophosphamide; and biologic: Belimumab, Rituximab or Abatacept. Our findings suggest that SLE disease activity is an independent risk factor for HPV infection, which has not been previously recognized. Reducing disease activity rather than immunosuppression may be the clinical approach to lower the risk for HPV infection. The biological basis for this association represents an important area for future study as is the role of disease activity in other infections among SLE patients."
Clinical • Addiction (Opioid and Alcohol) • Cervical Cancer • Gynecology • Human Papillomavirus Infection • Immunology • Infectious Disease • Inflammatory Arthritis • Lupus • Oncology • Solid Tumor • Systemic Lupus Erythematosus
|
|
Zehra Kazmi1; Carlos Lorenzo2; Agustin Escalante3
|